PATENT CLAIM ANALYSIS

Application Number: 16146625
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "252120"]

Abstract:
The present invention relates to deuterated 1-piperazino-3-phenyl-indanes and salts thereof with activity at dopamine receptors D 1  and D 2  as well as the 5HT 2  receptors in the central nervous system, to medicaments comprising such compounds as active ingredients, to the use of such compounds in the treatment of diseases in the central nervous system, and to methods of treatment comprising administration of such compounds.

Claim (Index 2):
The hydrogen fumarate salt of  claim 1 , wherein the compound is

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.75
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13527364', '13924849', '14656925', '15435826', '14941800']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8193533844543605
- 35 USC 102 Novelty (BERT): 0.5877649135661456
- Combined Prediction Score: 0.796194537365539
- Mean Citation Score: 483.802852
- Max Citation Score: 495.2152400000001
- Similarity Product: 421.673078286047

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test